SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19Julian Braun, Andreas Thiel, Lucie Loyal et al.|Nature|2020Cited by 1.4k
Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicansPetra Bächer, Alexander Scheffold, Christoph Ruwwe‐Glösenkamp et al.|Cell|2019Cited by 472
Lymphocyte Circadian Clocks Control Lymph Node Trafficking and Adaptive Immune ResponsesDavid Druzd, Christoph Scheiermann, Olga Matveeva et al.|Immunity|2017Cited by 449
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster ModelJakob Kreye, Harald Prüß, S. Momsen Reincke et al.|Cell|2020Cited by 387
Cross-reactive CD4 <sup>+</sup> T cells enhance SARS-CoV-2 immune responses upon infection and vaccinationLucie Loyal, Claudia Giesecke‐Thiel, Julian Braun et al.|Science|2021Cited by 315